Skip Nav Destination
Progressive silent cerebral infarction is associated with stroke and persistent cognitive impairment in survivors of iTTP
Pirtobrutinib, a highly selective, noncovalent (reversible) BTKi in R/R follicular lymphoma: phase 1/2 BRUIN study
Association of PET4 response with outcomes of BV-CHP vs CHOP in the ECHELON-2 trial in CD30+ peripheral T-cell lymphoma
International consensus guidelines for the conduct and reporting of CAR T-cell clinical trials in AML
Efficacy and safety of luspatercept in non–transfusion-dependent β-thalassemia: long-term results from the BEYOND study
Early clearance of circulating tumor DNA and association with odronextamab response in relapsed/refractory FL and DLBCL
NKTR-255 enhances complete response following CD19 CAR T-cell therapy in patients with relapsed/refractory large B-cell lymphoma
Issue Archive
December 9 2025
In Progress
Volume 9 Issue 23 | Blood Advances | American Society of Hematology
CLINICAL TRIALS AND OBSERVATIONS
Progressive silent cerebral infarction is associated with stroke and persistent cognitive impairment in survivors of iTTP
Clinical Trials & Observations
Jia Yu,Jenna Brown,Jay Meade,Gloria F. Gerber,Michael B. Streiff,Peggy Kraus,Samuel Merrill,Allyson M. Pishko,Jennifer Yui,Rakhi P. Naik,Robert A. Brodsky,Doris D. Lin,Shruti Chaturvedi
Pirtobrutinib, a highly selective, noncovalent (reversible) BTKi in R/R follicular lymphoma: phase 1/2 BRUIN study
Clinical Trials & Observations
Nirav N. Shah,Pier Luigi Zinzani,Michael Wang,Sunita D. Nasta,Ewa Lech-Maranda,Yoshiaki Ogawa,Bita Fakhri,Bryone Kuss,Kaname Miyashita,Krish Patel,Catherine C. Coombs,Shuo Ma,Manish R. Patel,Minal A. Barve,Benoit Tessoulin,Anastasios Stathis,Daisuke Ennishi,Daigo Hashimoto,Kensuke Kojima,Andrew D. Zelenetz,Jonathon B. Cohen,Julie M. Vose,Kami J. Maddocks,Talha Munir,Fangfang Sun,Yuanyuan Bian,Minna Balbas,Donald E. Tsai,Paolo Abada,Chan Y. Cheah
Association of PET4 response with outcomes of BV-CHP vs CHOP in the ECHELON-2 trial in CD30+ peripheral T-cell lymphoma
Clinical Trials & Observations
Swaminathan Iyer,Neha Mehta-Shah,Ranjana Advani,Nancy L. Bartlett,Jacob H. Christensen,Franck Morschhauser,Eva Domingo-Domenech,Giuseppe Rossi,Won Seog Kim,Onder Alpdogan,Tatyana A. Feldman,Vincent Camus,Giuseppe Gritti,Pier Luigi Zinzani,David Belada,Jiri Mayer,Ilseung Choi,June-Won Cheong,Evelyn Rustia,Keenan Fenton,Michelle Fanale,Kerry J. Savage,Steven M. Horwitz
International consensus guidelines for the conduct and reporting of CAR T-cell clinical trials in AML
Clinical Trials & Observations
Swati Naik,Richard Aplenc,Susanne H.C. Baumeister,Marco Becilli,Anand S. Bhagwat,Challice L. Bonifant,Lihua E. Budde,Christopher D. Chien,Kevin J. Curran,Anthony F. Daniyan,Alexandra Dreyzin,Rebecca A. Gardner,Sara Ghorashian,Stephen Gottschalk,LaQuisa C. Hill,M. Eric Kohler,Adam Lamble,Franco Locatelli,Maksim Mamonkin,Bilal Omer,Jae H. Park,Concetta Quintarelli,Benedetta Rambaldi,Rebecca M. Richards,David A. Sallman,Tim Sauer,Nirali N. Shah,Marion Subklewe,Corinne Summers,Sarah K. Tasian,Naomi Taylor,Sarah Tettamanti,Michael R. Verneris,M. Paulina Velasquez,Saar I. Gill
Efficacy and safety of luspatercept in non–transfusion-dependent β-thalassemia: long-term results from the BEYOND study
Clinical Trials & Observations
Ali T. Taher,Vip Viprakasit,Antonis Kattamis,Silverio Perrotta,Paolo Ricchi,John B. Porter,Thomas D. Coates,Gian Luca Forni,Khaled M. Musallam,Oriana Esposito,Richard Pilot,Wen-Ling Kuo,Yinzhi Lai,Marta Reverte,Richard Wei,Luciana Moro Bueno,Maria Domenica Cappellini
Early clearance of circulating tumor DNA and association with odronextamab response in relapsed/refractory FL and DLBCL
Clinical Trials & Observations
Jon E. Arnason,Matthew Matasar,Stefano Luminari,David Tucker,Dylan Sun,Weiwei Tao,Yuan O. Zhu,Kunal Kundu,Namita T. Gupta,Allen Leary,Vladimir Jankovic,Srikanth Ambati,Hesham Mohamed,Aafia Chaudhry,Jurriaan Brouwer-Visser
ADVANCES VIEWPOINT
MYELOID NEOPLASIA
Cardiovascular degeneration in Erdheim-Chester disease: prevalence, burden, and outcomes
Reema K. Tawfiq,Grant M. Spears,Jason R. Young,Madeline K. Mahowald,W. Oliver Tobin,Ubenthira Patgunarajah,Gordon J. Ruan,Dongni Yi,Saurabh Zanwar,Karen Rech,Matthew J. Koster,Aldo A. Acosta-Medina,Lucinda Gruber,Aishwarya Ravindran,Mithun Vinod Shah,N. Nora Bennani,Muhamad Alhaj Moustafa,Talal Hilal,Julio C. Sartori Valinotti,Robert Vassallo,Jay H. Ryu,Caroline Davidge-Pitts,Surendra Dasari,Thomas E. Witzig,Ronald S. Go,Gaurav Goyal,Jithma P. Abeykoon,on behalf of the Histio-Care Network
Statins enhance the efficacy of pegylated interferon-alfa2 in Philadelphia-negative chronic myeloproliferative neoplasms
Isabella Diana Davidsen,Morten Kranker Larsen,Lea Löffler,Vibe Skov,Lasse Kjær,Trine Alma Knudsen,Anders Lindholm Sørensen,Sarah Friis Christensen,Sabrina Cordua,Christina Schjellerup Eickhardt-Dalbøge,Marie Hvelplund Kristiansen,Christina Ellervik,Troels Wienecke,Hans Carl Hasselbalch
Lymphoid Neoplasia
Risk of synchronous and second primary malignancies in transplant-ineligible patients with multiple myeloma treated with lenalidomide
Thomas Systchenko,Laly Nsiala,Arthur Bobin,Hélène Gardeney,Carine Motard,Gaelle Olivier,Florence Borde,Anne Corby,Christophe Roul,Emmanuel Fleck,Guillaume Denis,Céline Dieval,Philippe Mottaz,Annick Boscagli,Gautier Defossez,Xavier Leleu
Identification of 4 autophagy-related genetic variants as risk factors for chronic lymphocytic leukemia
Antonio José Cabrera-Serrano,José Manuel Sánchez-Maldonado,Juan José Rodríguez-Sevilla,Fernando Jesús Reyes-Zurita,Rosa Collado,Anna Puiggros,Elena Cornejo-Calvo,Paloma García-Martín,Rob Ter Horst,Yolanda Benavente,Andrés Jerez,Stefano Landi,Blanca Espinet,Rossana Maffei,Miguel Ángel López-Nevot,Silvia Ramos-Campoy,Carmen González-Olmedo,Tzu-Hua Chen-Liang,Víctor Moreno,Fatin Jannus,Rafael Marcos-Gragera,María Carretero-Fernández,Belém Sampaio-Marques,Irene Gámez,María García-Álvarez,Nicola J. Camp,Trinidad Dierssen-Sotos,Joanna Kamaso,Eva María Pérez,Aaron D. Norman,Mario Luppi,Yang Li,Miguel Alcoceba,Daniele Campa,Silvia de San José,Roberto Marasca,Paula Ludovico,Alyssa Clay-Gilmour,Federico Canzian,Marian Ibañez,Mihai G. Netea,James McKay,Delphine Casabonne,Sonja I. Berndt,Susan L. Slager,Juan Sainz
Plasma Cell Disorders
Safety and efficacy of BCMA-directed chimeric antigen receptor T-cell therapy for the treatment of plasma cell leukemia
Gliceida M. Galarza Fortuna,Lauren Peres,Elena Nazarenko,Andre De Menezes Silva Corraes,Vanna N. Hovanky,Leyla Shune,Joseph McGuirk,Gabriel De Avilla,Jack Khouri,Danai Dima,Mahmoud Gaballa,Binod Dhakal,Peter Forsberg,Amandeep Godara,Aimaz Afrough,Larry Anderson,Megan M. Herr,James A. Davis,Hashim Mann,Sneha Purvey,William Clark,Myo Htut,Amer Beitinjaneh,Denise L. Pereira,Mehmet H. Kocoglu,Christopher James Ferreri,Shebli Atrash,Peter M. Voorhees,Adriana Rossi,Richard Shambavi,Hamza Hashmi,Krina Patel,Surbhi Sidana,Yi Lin,Doris K. Hansen,Douglas W. Sborov
THROMBOSIS AND HEMOSTASIS
Inside Blood Advances
RESEARCH LETTER
NKTR-255 enhances complete response following CD19 CAR T-cell therapy in patients with relapsed/refractory large B-cell lymphoma
Clinical Trials & Observations
Sairah Ahmed,John DiPersio,James Essell,Catherine Diefenbach,Miguel-Angel Perales,Cristina Castilla-Llorente,Saurabh Dahiya,Yi Liu,Heng Xu,Christie Fanton,Sohail Chaudhry,Zachary H. Lee,A. Mario Q. Marcondes,Mary A. Tagliaferri,Jonathan Zalevsky,David Miklos,Cameron J. Turtle,Joseph McGuirk
ERRATUM
SYSTEMATIC REVIEW
REVIEW ARTICLE
Harmonized immune recovery monitoring after HCT: evidence and practical guidance from the Westhafen Intercontinental Group
Taymour Hammoudi,Silvia Nucera,Alexandre G. Troullioud Lucas,Marc Ansari,Adriana Balduzzi,Alice Bertaina,Jochen Buechner,Selim Corbacioglu,Jean-Hugues Dalle,Krzystof Kalwak,Dean Lee,John E. Levine,Caroline A. Lindemans,Franco Locatelli,Roland Meisel,Stefan Nierkens,Giorgio Ottaviano,Antonio Perez-Martinez,Herbert Pichler,Susan E. Prockop,Michael A. Pulsipher,Julie-An M. Talano,Sanjay Tewari,Kirk R. Schultz,Nirali N. Shah,Michael R. Verneris,Jaap Jan Boelens,on behalf of the Westhafen Intercontinental Group
IMMUNOBIOLOGY AND IMMUNOTHERAPY
mTOR activity and metabolic reprogramming of CD8+ T cells is impaired under hypoxia and within the multiple myeloma bone marrow
Taylor Fulton-Ward,Nancy Gudgeon,Isaac Thirlwell,Emma L. Bishop,Bryan Marzullo,Hannah Giles,Graham McIlroy,Paul Ferguson,Bhuvan Kishore,Kate Rogers,Nuri Alfasi,Timothy Wong,Satnam Aytain,Daniel A. Tennant,Guy Pratt,Sarah Dimeloe
Advertisement intended for health care professionals
Advertisement intended for health care professionals


















Reporting infections in cellular therapies